{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:13:57Z","timestamp":1790828037754,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) is a severe hyperinflammatory disorder induced by overactivation of macrophages and T cells. This study aims to identify the risk factors for the progression from infectious mononucleosis (EBV-IM) to EBV-HLH, by analyzing the laboratory parameters of patients with EBV-IM and EBV-HLH and constructing a clinical prediction model. The outcome of this study carries important clinical value for early diagnosis and treatment of EBV-HLH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 60 patients diagnosed with EBV-HLH and 221 patients diagnosed with EBV-IM at our hospital between November 2018 and January 2024. Participants were randomly assigned to derivation and internal validation cohorts in a 7:3 ratio. LASSO regression and logistic regression analyses were employed to identify risk factors and construct the nomogram.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ferritin (OR, 213.139; 95% CI, 8.604-5279.703; P=0.001), CD3\n                      <jats:sup>-<\/jats:sup>\n                      CD16\n                      <jats:sup>+<\/jats:sup>\n                      CD56\n                      <jats:sup>+<\/jats:sup>\n                      % (OR, 0.011; 95% CI, 0-0.467; P=0.011), anti-EBV-NA-IgG (OR, 57.370; 95%CI, 2.976-1106.049; P=0.007), IL-6 (OR, 71.505; 95%CI, 2.118-2414.288; P=0.017), IL-10 (OR, 213.139; 95% CI, 8.604-5279.703; P=0.001) were identified as independent predictors of EBV-HLH. The prediction model demonstrated excellent discriminatory capability evidenced by an AUC of 0.997 (95% CI,0.993-1.000). When visualized using a nomogram, the ROC curves for the derivation and validation cohorts exhibited AUCs of 0.997 and 0.993, respectively. These results suggested that the model was highly stable and accurate. Furthermore, calibration curves and clinical decision curves indicated that the model possessed good calibration and offered significant clinical benefits.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The nomogram, which was based on these five predictors, exhibited robust predictive value and stability, thereby can be used to aid clinicians in the early detection of EBV-HLH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1503118","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:10:21Z","timestamp":1733357421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["A predictive model for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis"],"prefix":"10.3389","volume":"15","author":[{"given":"Rui","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leqiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Marsh","year":"2020","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1143181","article-title":"A predictive model for identifying secondary underlying diseases of hemophagocytic lymphohistiocytosis","volume":"14","author":"Gao","year":"2023","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.medmal.2009.06.004","article-title":"Syndrome d\u2019activation macrophagique et infection \u00e0 virus d\u2019Epstein-Barr chez l\u2019enfant","volume":"40","author":"Darteyre","year":"2010","journal-title":"M\u00e9decine Maladies Infectieuses"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-022-09285-w","article-title":"Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis","volume":"70","author":"Zhang","year":"2022","journal-title":"Immunologic Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101515","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/07853890.2022.2149850","article-title":"Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients","volume":"55","author":"Yao","year":"2022","journal-title":"Ann Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/bjh.17638","article-title":"Haemophagocytic lymphohistiocytosis and Epstein\u2013Barr virus: a complex relationship with diverse origins, expression and outcomes","volume":"196","author":"El-Mallawany","year":"2021","journal-title":"Br J Haematology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01493-9","article-title":"The clinical significance and prognostic role of whole-blood Epstein-Barr virus DNA in lymphoma-associated hemophagocytic lymphohistiocytosis","volume":"43","author":"Zhang","year":"2023","journal-title":"J Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0802-RA","article-title":"Hemophagocytic lymphohistiocytosis","volume":"146","author":"Ponnatt","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.08.004","article-title":"Hemophagocytic syndrome: primary forms and predisposing conditions","volume":"49","author":"Sepulveda","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01458-y","article-title":"A three-step screening procedure for early identification of children at high risk of hemophagocytic lymphohistiocytosis","volume":"43","author":"Li","year":"2023","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1186\/s12879-023-08654-6","article-title":"Comparative study of biomarkers for the early identification of Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis","volume":"23","author":"Cai","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1310.2016.08.002","article-title":"Principle suggestions for diagnosis and treatment of main nontumorous EpsteinBarr virusassociated diseases in children","volume":"54","year":"2016","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.07298.x","article-title":"Early diagnostic and prognostic significance of a specific Th1\/Th2 cytokine pattern in children with haemophagocytic syndrome","volume":"143","author":"Tang","year":"2008","journal-title":"Br J Haematology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus\u2013induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/his.14379","article-title":"The role of EBV in haematolymphoid proliferations: emerging concepts relevant to diagnosis and treatment","volume":"79","author":"Ababneh","year":"2021","journal-title":"Histopathology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105443","DOI":"10.1016\/j.meegid.2023.105443","article-title":"T cell-mediated immunity during Epstein\u2013Barr virus infections in children","volume":"112","author":"Liu","year":"2023","journal-title":"Infection Genet Evol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.10.001","article-title":"Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders","volume":"26","author":"Brisse","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2350-y","article-title":"Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis","volume":"94","author":"Dalal","year":"2015","journal-title":"Ann Hematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3809","article-title":"Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children","volume":"12","author":"An","year":"2016","journal-title":"Exp Ther Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1060053","article-title":"Characteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Pediatr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009499","article-title":"T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis","volume":"137","author":"Chaturvedi","year":"2021","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"155729","DOI":"10.1016\/j.cyto.2021.155729","article-title":"Significance of serum Th1\/Th2 cytokine levels in underlying disease classification of childhood HLH","volume":"149","author":"Zhao","year":"2022","journal-title":"Cytokine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13052-016-0262-7","article-title":"Comparison of Th1\/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis","volume":"42","author":"Chen","year":"2016","journal-title":"Ital J Pediatr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9583-x","article-title":"Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children","volume":"31","author":"Yanagimachi","year":"2011","journal-title":"J Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318219fd63","article-title":"Congenital hemophagocytic lymphohistiocytosis in a preterm infant","volume":"33","author":"Maruyama","year":"2011","journal-title":"J Pediatr Hematology\/Oncology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05132-6","article-title":"Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis","volume":"102","author":"Ou","year":"2023","journal-title":"Ann Hematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850443","article-title":"Simple evaluation of clinical situation and subtypes of pediatric hemophagocytic lymphohistiocytosis by cytokine patterns","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.06.017","article-title":"Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis\u2013like hyperinflammation and enhanced myelopoiesis","volume":"150","author":"Tang","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2013_096","article-title":"Determination of serological profiles and avidity of specific antibodies in the sera of patients with potential Epstein-Barr virus (EBV) infection","volume":"114","author":"Akpolat","year":"2013","journal-title":"Bratislava Med J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.07.053","article-title":"Ferritin in hemophagocytic lymphohistiocytosis (HLH): current concepts and controversies","volume":"510","author":"Sarangi","year":"2020","journal-title":"Clinica Chimica Acta"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1503118\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:10:25Z","timestamp":1733357425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1503118\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2024.1503118"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1503118","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"article-number":"1503118"}}